We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$163M
AUM Growth
+$11.9M
Cap. Flow
+$4.59M
Cap. Flow %
2.82%
Top 10 Hldgs %
51.37%
Holding
240
New
15
Increased
48
Reduced
45
Closed
31

Sector Composition

Rank Sector Weight
1 Technology 3.32%
2 Financials 2.41%
3 Healthcare 0.98%
4 Consumer Discretionary 0.66%
5 Consumer Staples 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMGF icon
176
iShares Emerging Markets Equity Factor ETF
EMGF
$1.82B
$30.2K 0.02%
736
VOE icon
177
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$29.8K 0.02%
220
SHY icon
178
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$29.5K 0.02%
363
AAIC
179
DELISTED
Arlington Asset Investment Corp.
AAIC
$29.3K 0.02%
10,000
SPSB icon
180
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$25.3K 0.02%
+862
New +$25.2K
RDIV icon
181
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.38B
$24.7K 0.02%
+567
New +$24.3K
OLMA icon
182
Olema Pharmaceuticals
OLMA
$1B
$24.5K 0.02%
10,000
BWZ icon
183
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$269M
$24.4K 0.02%
903
RPG icon
184
Invesco S&P 500 Pure Growth ETF
RPG
$2.01B
$18.2K 0.01%
600
IWR icon
185
iShares Russell Mid-Cap ETF
IWR
$56B
$18.1K 0.01%
268
VYM icon
186
Vanguard High Dividend Yield ETF
VYM
$80.9B
$16.2K 0.01%
150
INO icon
187
Inovio Pharmaceuticals
INO
$55.7M
$15.6K 0.01%
833
IRON icon
188
Disc Medicine
IRON
$2.96B
$13.5K 0.01%
10,000
+9,667
+2,903% +$481K
XERS icon
189
Xeris Biopharma Holdings
XERS
$1.39B
$13.3K 0.01%
10,000
VB icon
190
Vanguard Morningstar Small-Cap ETF
VB
$79.5B
$12.8K 0.01%
70
IWN icon
191
iShares Russell 2000 Value ETF
IWN
$14.3B
$11.1K 0.01%
80
REZ icon
192
iShares Residential and Multisector Real Estate ETF
REZ
$879M
$10.3K 0.01%
150
+4
+3% +$280
ICLN icon
193
iShares Global Clean Energy ETF
ICLN
$2.31B
$8.44K 0.01%
425
VO icon
194
Vanguard Morningstar Mid-Cap ETF
VO
$106B
$8.36K 0.01%
164
SPLV icon
195
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
$6.99K ﹤0.01%
109
IWS icon
196
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$5.16K ﹤0.01%
49
MOO icon
197
VanEck Agribusiness ETF
MOO
$972M
$4.29K ﹤0.01%
50
URA icon
198
Global X Uranium ETF
URA
$5.42B
$4.02K ﹤0.01%
200
SPYV icon
199
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$3.58K ﹤0.01%
92
VBR icon
200
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$3.49K ﹤0.01%
22

Similar funds

Running Point Capital Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Running Point Capital Advisors held 240 positions worth $163M, up 7.9% from $151M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Running Point Capital Advisors's Q4 2022 filing shows 15 new, 48 increased, 45 reduced and 31 closed positions. Its largest new stake was First Trust Managed Municipal ETF: 10,692 shares worth $536K. The largest sale was Meta Platforms (Facebook), an estimated $1.48M.

By sector, the portfolio is most concentrated in Technology at 3.3% of assets, down from 3.4% a quarter earlier, followed by Financials and Healthcare.

  • Running Point Capital Advisors's largest Q4 2022 buy was First Trust Managed Municipal ETF: 10,692 shares worth $536K.
  • Running Point Capital Advisors added most to Invesco NASDAQ 100 ETF in Q4 2022, an estimated $1.55M increase.
  • Running Point Capital Advisors's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.48M.
  • Running Point Capital Advisors fully exited Tesla in Q4 2022, selling an estimated $234K.
  • Running Point Capital Advisors's ten largest holdings make up 51% of its $163M portfolio in Q4 2022.
  • Running Point Capital Advisors opened 15 new positions and closed 31 in Q4 2022.
  • Running Point Capital Advisors's portfolio value rose 7.9% quarter-over-quarter to $163M.

Based on Running Point Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.